18/02/2021 | Pijplijn en groeikapitaal |
18/02/2021 | Pipeline and capital for growth |
10/02/2021 | Galapagos en Gilead zetten ISABELA Fase 3 studies in IPF stop |
10/02/2021 | Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF |
09/02/2021 | The Capital Group holds 10.03% of Galapagos shares |